Larimar Therapeutics
LRMR
#8510
Rank
NZ$0.25 B
Marketcap
$3.95
Share price
0.86%
Change (1 day)
-64.50%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.53

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.54. In 2022 the company made an earnings per share (EPS) of -$2.59 an increase over its 2021 EPS that were of -$4.99.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.53-40.92%
2022-$2.59-48.15%
2021-$4.99-14.27%
2020-$5.82